RxDoctor Payments Data

Robert Elder, MD

Family Medicine · Hartsville, SCNPI 1154353787

Payments from drug & device makers

$19,309in general payments, 2019–2025

Across 1,408 payments — averaging $13.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novo Nordisk$2K
  • Lilly USA, LLC$1K
  • AstraZeneca$1K
  • Boehringer Ingelheim$1K
  • Pfizer$907
  • plus $10K from 53 others

What the payments were for

  • Food & beverage$19,11999%
  • Education$1901%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)243$2,896
Novo Nordisk125$1,537
Lilly USA, LLC136$1,400
AstraZeneca(2 entities)64$1,193
Boehringer Ingelheim71$1,005
Pfizer68$907
Ironwood Pharmaceuticals, Inc57$895
GSK60$787
Merck66$776
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC49$704
Amgen(2 entities)43$673
Teva Pharmaceuticals USA, Inc.72$605
Supernus Pharmaceuticals, Inc.12$544
Astellas Pharma US Inc20$471
Johnson & Johnson33$442
Exact Sciences19$380
Amarin Pharma, Inc.25$364
Takeda Pharmaceuticals U.S.A., Inc.25$335
Novartis25$311
Sanofi-aventis U.S. LLC20$299
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)14$295
Biohaven Pharmaceuticals, Inc.19$269
Kowa Pharmaceuticals America, Inc.23$261
Forte Bio-pharma LLC6$162
Biohaven Pharmaceutical Holding Company Ltd.10$159
Otsuka America Pharmaceutical, Inc.9$152
Bayer9$132
Adlon Therapeutics L.p.7$123
Esperion Therapeutics, Inc.7$108
Nestle Healthcare Nutrition Inc.7$105
Lundbeck LLC5$104
Abbott6$82
E.r. Squibb & Sons, L.L.C.6$74
Boston Scientific3$63
Insulet Corporation3$60
Corcept Therapeutics3$55
Genentech USA, Inc.4$55
Scynexis, Inc.2$49
Dexcom, Inc.3$46
Shield Therapeutics Inc3$45
Avion Pharmaceuticals3$42
Xeris Pharmaceuticals, Inc.2$37
Upsher-smith Laboratories LLC2$34
Sunovion Pharmaceuticals Inc.2$33
Eisai Inc.2$28
Aytu Biopharma, Inc.2$26
Jazz Pharmaceuticals Inc.1$22
Antares Pharma, Inc.1$15
Cvrx, Inc.1$15
Halozyme Inc1$15
Tactile Systems Technology Inc1$15
Tolmar, Inc.1$14
Phathom Pharmaceuticals, Inc.1$14
Bausch Health US, LLC1$14
Paratek Pharmaceuticals, Inc.1$13
Mylan Specialty L.p.1$13
Hikma Pharmaceuticals USA1$12
Shire North American Group Inc1$12
Arbor Pharmaceuticals, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,309 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$889,293
Medicare patients
708
Services billed
14,689

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin223$213,104
MounjaroTirzepatide160$177,801
EliquisApixaban168$155,676
OzempicSemaglutide100$128,500
XareltoRivaroxaban98$81,615
FarxigaDapagliflozin Propanediol75$73,564
EntrestoSacubitril/Valsartan86$72,982
NuplazidPimavanserin Tartrate13$65,931
LinzessLinaclotide57$57,420
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$51,656
Tresiba Flextouch U-200Insulin Degludec36$44,659
MyrbetriqMirabegron37$29,290
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog31$29,084
Janumet XrSitagliptin Phos/Metformin Hcl20$27,868
RexultiBrexpiprazole19$27,022

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$1,005$232,820252 claims
Lilly USA, LLCMounjaro, Trulicity$1,400$198,217174 claims
PfizerEliquis$907$155,676168 claims
Novo NordiskOzempic$1,537$128,500100 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,193$108,236140 claims
Johnson & JohnsonXarelto$442$81,61598 claims
NovartisEntresto$311$72,98286 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$787$72,11290 claims
AbbVieLinzess$2,896$57,42057 claims
MerckJanumet Xr, Januvia$776$52,54041 claims
Astellas Pharma US IncMyrbetriq$471$29,29037 claims
Otsuka America Pharmaceutical, Inc.Rexulti$152$27,02219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Hartsville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →